MOALTRIA GROUP, INC.

NYSE altria.com


$ 43.39 $ -0.16 (-0.37 %)    

Friday, 26-Apr-2024 15:59:56 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 43.38
$ 43.52
$ 0.00 x 0
$ 0.00 x 0
$ 43.19 - $ 43.92
$ 37.33 - $ 44.02
13,794,252
na
74.51B
$ 0.66
$ 8.79
TBD
na
na ($ 0.09)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 10-26-2023 09-30-2023 10-Q
4 08-01-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 10-27-2022 09-30-2022 10-Q
8 07-28-2022 06-30-2022 10-Q
9 04-28-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 07-29-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 10-30-2020 09-30-2020 10-Q
16 07-30-2020 06-30-2020 10-Q
17 04-30-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 07-30-2019 06-30-2019 10-Q
21 04-25-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 10-25-2018 09-30-2018 10-Q
24 07-26-2018 06-30-2018 10-Q
25 04-26-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 10-26-2017 09-30-2017 10-Q
28 07-27-2017 06-30-2017 10-Q
29 05-02-2017 03-31-2017 10-Q
30 02-27-2017 12-31-2016 10-K
31 10-27-2016 09-30-2016 10-Q
32 07-27-2016 06-30-2016 10-Q
33 04-28-2016 03-31-2016 10-Q
34 02-25-2016 12-31-2015 10-K
35 10-29-2015 09-30-2015 10-Q
36 07-29-2015 06-30-2015 10-Q
37 04-23-2015 03-31-2015 10-Q
38 02-25-2015 12-31-2014 10-K
39 10-30-2014 09-30-2014 10-Q
40 07-22-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

https://www.washingtonpost.com/health/2024/04/26/menthol-cigarette-ban-delayed-biden-administration/

Core News & Articles

https://www.wsj.com/politics/policy/menthol-cigarette-ban-explained-0c41df7a?mod=latest_headlines   

 altria-ceo-urges-fda-crackdown-on-illicit-vape-products-report

Altria CEO, Billy Gifford, urges FDA crackdown on illicit vape products, highlighting public health risks. NJOY's retail ex...

 stocks-drop-tech-tumbles-with-metas-weak-outlook-q1-stagflation-fears-gold-miners-advance-whats-driving-markets-thursday

Wall Street suffers a double blow in Thursday’s session, as softer-than-expected revenue forecasts from Meta Platforms Inc. (NA...

 altrias-marlboro-shipment-volume-plunges-87-in-q1---whats-going-on

Altria Group beats expectations with a 2.5% year-on-year sales growth to $5.58 billion in Q1 FY24. Despite a decline in smokeab...

 altria-group-q1-2024-gaap-eps-115-inline-sales-558b-beat-471b-estimate

Altria Group (NYSE:MO) reported quarterly earnings of $1.15 per share which met the analyst consensus estimate. The company re...

 us-stocks-brace-for-negative-start-amid-tech-earnings-disappointments-caution-ahead-of-data-worst-of-this-two-week-decline-is-behind-us-says-analyst

The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platfor...

 can-magnificent-7-help-script-market-turnaround-earnings-pick-up-pace-with-microsoft-meta-alphabet-and-tesla-expected-this-week

Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.

 ubs-maintains-sell-on-altria-group-raises-price-target-to-365

UBS analyst Faham Baig maintains Altria Group (NYSE:MO) with a Sell and raises the price target from $36.1 to $36.5.

 biden-government-again-missed-menthol-cigarettes-ban-deadline-lawsuit-challenges-fdas-delay

Facing delays, the FDA's proposal to ban menthol cigarettes in the US encounters setbacks as White House officials miss yet...

 stifel-reiterates-buy-on-altria-group-maintains-50-price-target

Stifel analyst Matthew Smith reiterates Altria Group (NYSE:MO) with a Buy and maintains $50 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION